Article
Management of Patients With Histologic Transformation.
Clinical lymphoma, myeloma & leukemia - 1 Jul 2017
Reddy Nishitha M
Abstract excerpt
The incidence of histological transformation is up to 30% over a period of 10 years. This risk persists even beyond the initial decade of diagnosis of an indent lymphoma. In this era of emerging novel therapies, one could hope for an improved survival. There are currently no randomized trials guiding therapy for transformed lymphoma. Treatment recommendations are based on observational studies or non-randomized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
